GW Henssler & Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$375K Hold
3,382
0.02% 139
2025
Q1
$379K Sell
3,382
-188,811
-98% -$21.2M 0.02% 130
2024
Q4
$16.1M Sell
192,193
-2,355
-1% -$197K 0.92% 51
2024
Q3
$16.3M Sell
194,548
-4,450
-2% -$373K 0.92% 50
2024
Q2
$13.7M Buy
198,998
+2,442
+1% +$168K 0.82% 54
2024
Q1
$14.4M Buy
196,556
+3,176
+2% +$233K 0.85% 54
2023
Q4
$15.7M Sell
193,380
-2,329
-1% -$189K 1.03% 45
2023
Q3
$14.7M Sell
195,709
-946
-0.5% -$70.9K 1% 48
2023
Q2
$15.2M Buy
196,655
+337
+0.2% +$26K 1% 47
2023
Q1
$16.3M Sell
196,318
-2,813
-1% -$233K 1.08% 44
2022
Q4
$17.1M Sell
199,131
-1,344
-0.7% -$115K 1.2% 38
2022
Q3
$12.4M Buy
200,475
+26,479
+15% +$1.63M 0.93% 49
2022
Q2
$10.8M Sell
173,996
-19,409
-10% -$1.2M 0.8% 53
2022
Q1
$11.5M Buy
193,405
+10,657
+6% +$634K 0.7% 56
2021
Q4
$13.3M Buy
182,748
+1,448
+0.8% +$105K 0.85% 50
2021
Q3
$12.7M Sell
181,300
-11,310
-6% -$790K 0.88% 54
2021
Q2
$13.3M Buy
192,610
+5,320
+3% +$366K 0.87% 53
2021
Q1
$12.1M Buy
187,290
+42,050
+29% +$2.72M 0.87% 56
2020
Q4
$8.46M Sell
145,240
-34,131
-19% -$1.99M 0.65% 60
2020
Q3
$11.3M Buy
179,371
+2,025
+1% +$128K 0.96% 51
2020
Q2
$13.6M Sell
177,346
-6,227
-3% -$479K 1.2% 39
2020
Q1
$13.7M Buy
183,573
+2,978
+2% +$223K 1.39% 33
2019
Q4
$11.7M Sell
180,595
-2,566
-1% -$167K 0.97% 44
2019
Q3
$11.6M Buy
183,161
+1,004
+0.6% +$63.6K 1.03% 42
2019
Q2
$12.3M Buy
182,157
+1,708
+0.9% +$115K 1.11% 38
2019
Q1
$11.7M Buy
180,449
+20,240
+13% +$1.32M 1.08% 42
2018
Q4
$10M Sell
160,209
-17,665
-10% -$1.1M 1.07% 40
2018
Q3
$13.7M Buy
177,874
+2,301
+1% +$178K 1.25% 34
2018
Q2
$12.4M Buy
175,573
+4,769
+3% +$338K 1.22% 36
2018
Q1
$12.9M Buy
170,804
+334
+0.2% +$25.2K 1.29% 31
2017
Q4
$12.2M Buy
170,470
+3,414
+2% +$245K 1.14% 39
2017
Q3
$13.5M Buy
167,056
+6,547
+4% +$530K 1.36% 24
2017
Q2
$11.4M Buy
160,509
+11,880
+8% +$841K 1.18% 34
2017
Q1
$10.1M Buy
+148,629
New +$10.1M 1.09% 41